Product Details

Jyna Emtricitabine and Tenofovir Disoproxil Fumarate##

Emtricitabine; Tenofovir Disoproxil Fumarate
200 mg; 300 mg
Tablet

ROA

Oral

Applicant Name

Jyna Pharma Ltd

NRN

C4-0479

Status

Active


Composition

Each film Coated Tablet contains: Emtricitabine 200 mg, Tenofovir Disoproxil Fumarate 300 mg equivalent to Tenofovir Disoproxil 245 mg This medicinal product contains: Lactose (Anhydrous) 145 mg in core and 8.40 mg (28.0 % of 30 mg) in the film coat of Lactose Monohydrate Excipients q.s.  

ATC Code

J05AR03  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

 

Product Description

Film Coated Tablet. Blue colored, capsule shaped, film coated biconvex tablets, debossed with “LA49” on one side and plain on the other side "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS ARE INDICATED IN ANTIRETROVIRAL COMBINATION THERAPY FOR THE TREATMENT OF HIV-1 INFECTED ADULTS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS ARE ALSO INDICATED FOR THE TREATMENT OF HIV-1 INFECTED ADOLESCENTS, WITH NRTI RESISTANCE OR TOXICITIES PRECLUDING THE USE OF FIRST LINE AGENTS."

Manufacturer Name

Laurus Labs Limited

Manufacturer Country

INDIA  

Approval Date

2021-05-07  

Expiry Date

2026-05-06